Small Airway Mucous Metaplasia and Inflammation in Chronic Obstructive Pulmonary Disease
暂无分享,去创建一个
V. Kim | J. Gaughan | G. Criner | T. Rogers | C. Solomides | B. Dickey | C. Evans | S. Kelemen | Mohammad Abuel-Haija | A. Sharafkaneh | Amir Sharafkaneh
[1] David J Erle,et al. IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production. , 2007, American journal of respiratory cell and molecular biology.
[2] A. Agustí,et al. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease , 2006, Clinical and experimental immunology.
[3] B. Make,et al. Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease. , 2006, Proceedings of the American Thoracic Society.
[4] I. Adcock,et al. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.
[5] R. Djukanović,et al. Inflammatory cells in the airways in COPD , 2006, Thorax.
[6] Amir Sharafkhaneh,et al. Airway mucus: From production to secretion. , 2006, American journal of respiratory cell and molecular biology.
[7] H. Deshmukh,et al. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. , 2005, American journal of respiratory and critical care medicine.
[8] B. Stripp,et al. Mucin is produced by clara cells in the proximal airways of antigen-challenged mice. , 2004, American journal of respiratory cell and molecular biology.
[9] D. Corry,et al. An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema , 2004, PLoS medicine.
[10] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[11] L. Fabbri,et al. Interleukin‐13 and ‐4 expression in the central airways of smokers with chronic bronchitis , 2003, European Respiratory Journal.
[12] M. Cosio,et al. Pathophysiology of the small airways. , 2003, Seminars in respiratory and critical care medicine.
[13] D. Corry,et al. A Protease-Activated Pathway Underlying Th Cell Type 2 Activation and Allergic Lung Disease1 , 2002, The Journal of Immunology.
[14] B. Beghé,et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. , 2002, American journal of respiratory and critical care medicine.
[15] P. Paré,et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.
[16] M. Saetta,et al. Pathogenesis and Pathology of COPD , 2001, Respiration.
[17] M. Miravitlles,et al. Factors Associated with Increased Risk of Exacerbation and Hospital Admission in a Cohort of Ambulatory COPD Patients: A Multiple Logistic Regression Analysis , 2000, Respiration.
[18] L. Fabbri,et al. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. , 2000, American journal of respiratory and critical care medicine.
[19] M. Corradi,et al. Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. , 1999, The Journal of allergy and clinical immunology.
[20] L. Fabbri,et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.
[21] L. Fabbri,et al. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. , 1997, American journal of respiratory and critical care medicine.
[22] M. Stacey,et al. The role of CD8+ Th2 lymphocytes in the development of smoking-related lung damage. , 1997, Biochemical and biophysical research communications.
[23] J. Vestbo,et al. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.
[24] W. MacNee,et al. Factors affecting neutrophil transit during acute pulmonary inflammation: minireview. , 1993, Experimental lung research.
[25] P. Schnohr,et al. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. , 1990, Thorax.
[26] H. Yaegashi,et al. Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.
[27] D. Hyde,et al. Regional differences in quantities of histochemically detectable mucosubstances in nasal, paranasal, and nasopharyngeal epithelium of the bonnet monkey. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[28] V. Kim,et al. Small airway morphometry and improvement in pulmonary function after lung volume reduction surgery. , 2005, American journal of respiratory and critical care medicine.
[29] J. Tyner,et al. Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.